Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (655) Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet, GlaxoSmithKline,
...Newly Approved Drug Therapies (655) Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet, GlaxoSmithKline, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet Company: GlaxoSmithKline Approval Status: Approved November 2000 Treatment Area: HIV ...
View Page

2. Clinical Trial Results by Drug Names
...Study: A Controlled Phase II Trial Assessing 3 Doses of T-20 in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Fast Facts: Protocol number: T20-206 Sponsor ...
...evaluate the safety, efficacy, and plasma pharmacokinetics ( PK) of T-20 (Fuzeon) in combination with Abacavir (ABC), Amprenavir (APV), Ritonavir (RTV), and Efavirenz (EFV) in Human Immunodeficiency Virus Type-1 ( HIV ...
View Page

3. Advanced/Specific Search Results Fuzeon [enfuvirtide]
...II A Controlled Phase II Trial Assessing 3 Doses of T-20 in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Product Name: Fuzeon [enfuvirtide] Date of Report ...
View Page

4. Clinical Trial Results: HIV Infections
...II A Controlled Phase II Trial Assessing 3 Doses of T-20 in Combination with Abacavir, Amprenavir, Ritonavir, and Efavirenz in HIV-Infected Adults Product Name: Fuzeon [enfuvirtide] Date of Report ...
View Page

5.  Newly Approved Drug Therapies (844) Lexiva (fosamprenavir calcium), GlaxoSmithKline,
...1,250 mg twice daily) in 249 antiretroviral treatment-naive subjects. Both groups also received abacavir (300 mg twice daily) and lamivudine (150 mg twice daily). Results showed that the median ...
...1,250 mg twice daily) in 649 treatment-naive subjects. Both treatment groups also received abacavir (300 mg twice daily) and lamivudine (150 mg twice daily). Results showed that the median ...
View Page

6.  Study Posting (2348) Trial #149983, Hepatitis B, New York, NY
...dipivoxil is a nucleoside analogues. Some other examples of nucleoside analogues include Lamivudine, Emtricitabine, and Abacavir. Participation in this study is expected to last about 2 years. During the first year ...
View Page

7.  Newly Approved Drug Therapies (936) Tyzeka (telbivudine), Idenix Pharma,
...the anti-HBV combination activity relationships of telbivudine in cell culture with the HIV NRTIs abacavir, emtricitabine, lamivudine, tenofovir, zalcitibine, and zidovudine. Protocol Submission: February 2007 Final Report Submission: November 2007 ...
View Page

8.  CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies
...Vaginal Cream ; Taro Pharmaceuticals; For the treatment of vaginal yeast infections, Approved April 2000 Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet ; GlaxoSmithKline; For the treatment of HIV-1 infection, Approved November ...
View Page

9.  CenterWatch: List of Newly Approved Drug Thearapies
...Vaginal Cream ; Taro Pharmaceuticals; For the treatment of vaginal yeast infections, Approved April 2000 Trizivir (abacavir sulfate; lamivudine; zidovudine AZT) Tablet ; GlaxoSmithKline; For the treatment of HIV-1 infection, Approved November ...
View Page

10. Clinical Trial Results by Drug Names
...followed by a maintenance phase of 34 weeks, in which the group A was given abacavir in combination with lamivudine and zidovudine, while the group B received lopinavir/ritonavir in combination ...
View Page